日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia.

利用 CRISPR/Cas9 技术改造的通用 CD123/B7-H3 串联 CAR-T 细胞用于治疗急性髓系白血病。

Li Hexian, Lu Qizhong, Yu Zhengyu, Wu Zhiguo, Zhu Zhixiong, Li Jia, Zhang Zongliang, Wang Zeng, Yang Nian, Chen Yongdong, Lu Huaqing, Niu Ting, Tong Aiping

Aberrant CD25 and Increased CD123 Expression Are Common in Acute Myeloid Leukemia with KMT2A Partial Tandem Duplication and Are Associated with FLT3 Internal Tandem Duplication

异常的CD25和CD123表达增加在伴有KMT2A部分串联重复的急性髓系白血病中很常见,并且与FLT3内部串联重复相关。

Wei, Qing; Tang, Guilin; Li, Shaoying; Wang, Sa A; Lin, Pei; Wang, Wei; Loghavi, Sanam; Wang, Wei J; Medeiros, L Jeffrey; Xu, Jie

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS

双特异性固有免疫细胞衔接器AFM28可清除急性髓系白血病(AML)和骨髓增生异常综合征(MDS)中的CD123+白血病干细胞和祖细胞。

Nanni Schmitt # ,Jana-Julia Siegler # ,Alexandra Beck ,Thomas Müller ,Izabela Kozlowska ,Séverine Sarlang ,Uwe Reusch ,Stefan Knackmuss ,José Medina-Echeverz ,Joachim Koch ,Thorsten Ross ,Ali Darwich ,Lea Hoppe ,Mohammed Abba ,Alexander Streuer ,Stefan Klein ,Wolf-Karsten Hofmann ,Anna Lisa Gündner ,Christian Merz ,Jan Endell ,Jens Pahl ,Daniel Nowak

CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells

CD33-CD123 IF-THEN 门控可降低 AML 靶向 CAR-T 细胞的毒性,同时增强其特异性和记忆表型。

Jambon, Samy; Sun, Jianping; Barman, Shawn; Muthugounder, Sakunthala; Bito, Xue Rachel; Shadfar, Armita; Kovach, Alexandra E; Wood, Brent L; Thoppey Manoharan, Varsha; Morrissy, A Sorana; Bhojwani, Deepa; Wayne, Alan S; Pulsipher, Michael A; Kim, Yong-Mi; Asgharzadeh, Shahab; Parekh, Chintan; Moghimi, Babak

Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia

疫苗诱导的T细胞和CD123双特异性T细胞衔接器用于治疗急性髓系白血病

Liegel, Jessica; Stroopinsky, Dina; Cheloni, Giulia; Karagkouni, Dimitra; Nahas, Myrna; Ma, Yuling; Torres, Daniela; Saldarriaga, Isabella; Wang, Shuoshuo; Arruda de Amaral, Antonella; Ploumakis, Athanasios; Clohessy, John; Abirached, Joseph; Bisharat, Lina; Fraenkel, Paula; Yildirim, Ozlem; Bonnevaux, Hélène; Guerif, Stephane; Rallis, Katie; Chedid, Georges; Kufe, Donald; Vlachos, Ioannis S; Avigan, David; Rosenblatt, Jacalyn

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities

达沙替尼和帕纳替尼对CD123 CAR-T细胞功能调控的评价

Mantion, Charles-Frédéric; Biichlé, Sabeha; Roussel, Xavier; Rolin, Gwenaël; Lejeune, Agathe; Labaigt, Tony; Bôle-Richard, Elodie; Daguindau, Etienne; Royer, Bernard; Renosi, Florian; Adotevi, Olivier; Loyon, Romain; Fredon, Maxime; Garnache-Ottou, Francine

Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm

靶向 CD123 和 CD303 的免疫疗法:治疗浆细胞样树突状细胞肿瘤的新前沿

Galati, Domenico; Zanotta, Serena; Florio, Fabrizia; Mele, Sara; De Filippi, Rosaria; Pinto, Antonio

OPG and BAFF as predictive biomarkers of the severity of SARS-CoV-2 infection

OPG 和 BAFF 作为 SARS-CoV-2 感染严重程度的预测生物标志物

Andy Ruiz, Carlos Peña-Bates, Lucero A Ramon-Luing, Daniel Baca-Nuñez, Marco Antonio Vargas, Karen Medina-Quero, Neptali Gutierrez, Joel A Vázquez-Pérez, Ramcés Falfán-Valencia, Gloria Pérez-Rubio, Carolina Di Benedetto, Ivette Buendia-Roldan, Moisés Selman, Paola Betancur, Leslie Chavez-Galan

Integrating CRISPR-Cas12a with Aptamer as a Logic Gate Biosensing Platform for the Detection of CD33 and CD123

将 CRISPR-Cas12a 与适体整合为逻辑门生物传感平台用于检测 CD33 和 CD123

Yang, Xinyi; Shi, Xiaolong; Lv, Chenyu; Liu, Wenbin; Zhang, Fengyue; Liu, Bo

CD123-targeting immunotherapeutic approaches in acute myeloid leukaemia

CD123靶向免疫疗法在急性髓系白血病中的应用

Dreyzin, Alexandra; Holtzman, Noa G; Bonifant, Challice L